Navigation thread
Cellular immunotherapies for cancer
Featured projects
-
Fine-tuning T cell networks of exhaustion by synthetic sensors
Principal investigator: Sònia Guedan Carrió.Funder: European Commission.Code: HORIZON-EIC-2021-Pathfinder.Duration: 01/09/2022 - 30/08/2026Development of enabling technologies for T-cell immunotherapy
Principal investigator: Sònia Guedan Carrió.Funder: Fundación La Caixa.Code: Health Research_2021.Duration: 01/10/2021 - 30/09/2024T2EVOLVE: Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy
Principal investigator: Sònia Guedan Carrió.Funder: European Commission.Code: CE_IMI12_18th_2stg.Duration: 01/01/2021 - 31/12/2025CAR-T cells as drug delivery agents for the treatment of solid tumors
Principal investigator: Sònia Guedan Carrió.Funder: Asociación Española Contra el Cáncer.Code: AECC_Lab20.Duration: 01/12/2020 - 29/02/2024Chimeric Antigen Receptor (CAR)-modified T cells for the treatment of solid tumours
Principal investigator: Sònia Guedan Carrió.Funder: Agencia Estatal de Investigacion (AEI).Code: PID2019-109546RA-I00.Duration: 01/06/2020 - 31/05/2023Major founders
The research of this group can be carried out thanks to the funders.
-
. This link opens in a new tab. EIC Pathfinder
-
. This link opens in a new tab. European Commission
-
. This link opens in a new tab. Fundació ”la Caixa”
-
. This link opens in a new tab. Fundación AECC
-
. This link opens in a new tab. Innovatives Medicine Innitiative
-
. This link opens in a new tab. Ministerio de Ciencia e Innovación
-
. This link opens in a new tab. Spark-Roche
-
. This link opens in a new tab. The Follicular Lymphoma Foundation CURE FL award
More about researchCheck job offersIDIBAPS looks for talented professionals to meet the needs that appear periodically.
Enter
